SRAM
BIO icon

Stone Ridge Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Stone Ridge Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,707
Closed -$568K – 956
2019
Q3 		$568K Hold
1,707
– – 0.03% 635
2019
Q2 		$534K Hold
1,707
– – 0.03% 694
2019
Q1 		$522K Hold
1,707
– – 0.03% 700
2018
Q4 		$396K Hold
1,707
– – 0.02% 882
2018
Q3 		$534K Hold
1,707
– – 0.03% 814
2018
Q2 		$493K Hold
1,707
– – 0.03% 796
2018
Q1 		$427K Hold
1,707
– – 0.02% 866
2017
Q4 		$407K Buy
+1,707
New +$414K 0.03% 915

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return